3.0
Jun 16, 2012
Current employee, more than 3 years
Recommend
CEO approval
Business Outlook
Pros
- very diverse product portfolio (Renal, Nutrition, Hemophilia, Oncology etc) and are all acute care based hence higher margins - company employees and management truly believe in saving and sustaining lives - R&D spend of $1B annually - good corporate citizen and cares for employees
Cons
- very profitable hence there is a lower sense of urgency in employees and management. Slow and fractured decision making - limited success with R&D spend in terms of new products or margin improvement. Low accountability - management team in general is old school and disconnected with rank and file. Employee surveys reflect this.
